Prognostic Assessment in Patients With Primary Diffuse Large B‐Cell Lymphoma of the Central Nervous System Using MRI‐Based Radiomics

Author:

Liu Jianpeng1ORCID,Tu Jiaqi1,Hu Bin1,Li Chao2,Piao Sirong1,Lu Yucheng1,Li Anning3,Ding Tianling4,Xiong Ji5,Zhu Fengping6,Li Yuxin1ORCID

Affiliation:

1. Department of Radiology, Huashan Hospital Fudan University Shanghai China

2. Department of Clinical Neuroscience University of Cambridge Cambridge UK

3. Department of Radiology, Qilu Hospital Shandong University Jinan China

4. Department of Haematology, Huashan Hospital Fudan University Shanghai China

5. Department of Pathology, Huashan Hospital Fudan University Shanghai China

6. Department of Neurosurgery, Huashan Hospital Fudan University Shanghai China

Abstract

BackgroundPrimary central nervous system lymphoma (PCNSL) carries a poor prognosis. Radiomics may hold potential value in prognostic assessment.PurposeTo develop and validate an MRI‐based radiomics model and combine it with clinical factors to assess progression‐free survival (PFS) and overall survival (OS) of patients with PCNSL.Study TypeRetrospective and prospective.PopulationThree hundred seventy‐nine patients (179 female, 53 ± 7 years) from 2014 to 2022.Field Strength/SequenceT2/fluid‐attenuated inversion recovery, contrast‐enhanced T1WI and diffusion‐weighted echo‐planar imaging sequences on 3.0 T.AssessmentRadiomics features were extracted from enhanced tumor regions on preoperative multi‐sequence MRI. Using a least absolute shrinkage and selection operator (LASSO) Cox regression model to select radiomic signatures in training cohort (N = 169). Cox proportional hazards models were constructed for clinical, radiomics, and combined models, with internal (N = 72) and external (N = 32) cohorts validating model performance.Statistical TestsChi‐squared, Mann–Whitney, Kaplan–Meier, log‐rank, LASSO, Cox, decision curve analysis, time‐dependent Receiver Operating Characteristic, area under the curve (AUC), and likelihood ratio test. P‐value <0.05 was considered significant.ResultsFollow‐up duration was 28.79 ± 22.59 months (median: 25). High‐risk patients, determined by the median radiomics score, showed significantly lower survival rates than low‐risk patients. Compared with NCCN‐IPI, conventional imaging and clinical models, the combined model achieved the highest C‐index for both PFS (0.660 internal, 0.802 external) and OS (0.733 internal, 0.781 external) in validation. Net benefit was greater with radiomics than with clinical alone. The combined model exhibited performance with AUCs of 0.680, 0.752, and 0.830 for predicting 1‐year, 3‐year, and 5‐year PFS, and 0.770, 0.789, and 0.863 for OS in internal validation, with PFS AUCs of 0.860 and 0.826 and OS AUCs of 0.859 and 0.748 for 1‐year and 3‐year survival in external validation.Data ConclusionIncorporating a multi‐sequence MR‐based radiomics model into clinical models enhances the assess accuracy for the prognosis of PCNSL.Evidence Level4Technical EfficacyStage 2

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3